NCT04479540View on ClinicalTrials.gov

Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease

NACompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

May 26, 2020

Primary Completion Date

February 26, 2022

Study Completion Date

March 5, 2022

Conditions
Pneumonia, Viral
Interventions
RADIATION

Angiography scanner

systematic thoracic angiography scanner to diagnose pulmonary embolism and additional blood sample (hemostasis exploration)

Trial Locations (1)

92150

Hôpital Foch, Suresnes

All Listed Sponsors
collaborator

Hospital Ambroise Paré Paris

OTHER

collaborator

University Hospital, Brest

OTHER

lead

Hopital Foch

OTHER

NCT04479540 - Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease | Biotech Hunter | Biotech Hunter